Vikram Sinha

3.3k total citations
76 papers, 2.4k citations indexed

About

Vikram Sinha is a scholar working on Surgery, Statistics and Probability and Pediatrics, Perinatology and Child Health. According to data from OpenAlex, Vikram Sinha has authored 76 papers receiving a total of 2.4k indexed citations (citations by other indexed papers that have themselves been cited), including 20 papers in Surgery, 17 papers in Statistics and Probability and 16 papers in Pediatrics, Perinatology and Child Health. Recurrent topics in Vikram Sinha's work include Statistical Methods in Clinical Trials (17 papers), Diabetes Management and Research (15 papers) and Pharmaceutical studies and practices (15 papers). Vikram Sinha is often cited by papers focused on Statistical Methods in Clinical Trials (17 papers), Diabetes Management and Research (15 papers) and Pharmaceutical studies and practices (15 papers). Vikram Sinha collaborates with scholars based in United States, United Kingdom and Singapore. Vikram Sinha's co-authors include Ping Zhao, Vicky Hsu, Christian Wagner, Joseph A. Grillo, Dinesh P. de Alwis, S-M Huang, Scott J. Jacober, Yuzhuo Pan, Lokesh Jain and Daniel C. Howey and has published in prestigious journals such as Journal of Clinical Oncology, Diabetes Care and Cancer Research.

In The Last Decade

Vikram Sinha

72 papers receiving 2.3k citations

Peers

Countries citing papers authored by Vikram Sinha

Since Specialization

Citations

This map shows the geographic impact of Vikram Sinha's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Vikram Sinha with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Vikram Sinha more than expected).

Fields of papers citing papers by Vikram Sinha

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Vikram Sinha. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Vikram Sinha. The network helps show where Vikram Sinha may publish in the future.

Co-authorship network of co-authors of Vikram Sinha

This figure shows the co-authorship network connecting the top 25 collaborators of Vikram Sinha. A scholar is included among the top collaborators of Vikram Sinha based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Vikram Sinha. Vikram Sinha is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Considerations for Industry—Preparing for the FDA Model‐Informed Drug Development (MIDD) Paired Meeting Program 2024 ·Clinical Pharmacology & Therapeutics ·Gerald R. Galluppi, Malidi Ahamadi, (unknown), Nageshwar Budha, Ferdous Gheyas, Chi‐Chung Li, Yuan Chen, Anne‐Gaëlle Dosne, Niels Rode Kristensen, Mindy Magee, Mahesh N. Samtani, Vikram Sinha, Kunal S. Taskar, Vijay Upreti, Jianning Yang, Jack Cook	6
2	Drafting a pro-antitrust and data protection regulatory framework 2023 ·(unknown), Vikram Sinha, (unknown)	3
3	The great cover up: Environmental toll of excessive surgical draping in minimally invasive surgery 2023 ·Journal of Plastic Reconstructive & Aesthetic Surgery ·Vikram Sinha, (unknown), (unknown)	1
4	Clinical Pharmacology of Brigatinib: A Next-Generation Anaplastic Lymphoma Kinase Inhibitor 2023 ·Clinical Pharmacokinetics ·Neeraj Gupta, Michael J. Hanley, Robert Griffin, Pingkuan Zhang, Karthik Venkatakrishnan, Vikram Sinha	7
5	The quality of online information regarding non-surgical aesthetic procedures 2020 ·Journal of Plastic Reconstructive & Aesthetic Surgery ·Vikram Sinha, (unknown), Mimi R. Borrelli, (unknown), (unknown)	5
6	A systematic review and meta-analysis of antibiotic prophylaxis in skin graft surgery: A protocol 2019 ·PubMed ·Mimi R. Borrelli, Vikram Sinha, (unknown), (unknown), (unknown), Riaz Agha, Alastair D. MacKenzie Ross	2
7	Pembrolizumab Exposure–Response Assessments Challenged by Association of Cancer Cachexia and Catabolic Clearance 2018 ·Clinical Cancer Research ·David C. Turner, Anna Kondic, Keaven M. Anderson, Andrew Robinson, Edward B. Garon, Jonathan W. Riess, Lokesh Jain, Kapil Mayawala, Jiannan Kang, Scot Ebbinghaus, Vikram Sinha, Dinesh P. de Alwis, Julie A. Stone	156
8	Development of Drug Therapies for Newborns and Children 2017 ·Pediatric Clinics of North America ·Yeruk Mulugeta, Anne Zajicek, Jeff Barrett, Hari Cheryl Sachs, Susan McCune, Vikram Sinha, Lynne Yao	21
9	Role of Quantitative Clinical Pharmacology in Pediatric Approval and Labeling 2016 ·Drug Metabolism and Disposition ·Nitin Mehrotra, Atul Bhattaram, Justin Earp, (unknown), Kevin Krudys, Jung Eun Lee, (unknown), Jiaming Liu, Yeruk Mulugeta, Jiajie Yu, Ping Zhao, Vikram Sinha	58
10	Applying Regulatory Science to Develop Safe and Effective Medicines for Neonates: Report of the US Food and Drug Administration First Annual Neonatal Scientific Workshop, October 28–29, 2014 2015 ·Therapeutic Innovation & Regulatory Science ·Martin Offringa, Jonathan M. Davis, M. Turner, Robert M. Ward, Ralph Bax, (unknown), Vikram Sinha, Susan McCune, Anne Zajicek, Daniel K. Benjamin, Christina Bucci‐Rechtweg, Robert M. Nelson	7
11	Quantitative characterization of circadian rhythm of pulmonary function in asthmatic patients treated with inhaled corticosteroids 2015 ·Journal of Pharmacokinetics and Pharmacodynamics ·Di Zhou, Hongshan Li, Yaning Wang, Günther Hochhaus, Vikram Sinha, Liang Zhao	5
12	Predicting the Effect of CYP3A Inducers on the Pharmacokinetics of Substrate Drugs Using Physiologically Based Pharmacokinetic (PBPK) Modeling: An Analysis of PBPK Submissions to the US FDA 2015 ·Clinical Pharmacokinetics ·Christian Wagner, Yuzhuo Pan, Vicky Hsu, Vikram Sinha, Ping Zhao	78
13	Single‐dose pharmacokinetics and glucodynamics of the novel, long‐acting basal insulin LY2605541 in healthy subjects 2014 ·The Journal of Clinical Pharmacology ·Vikram Sinha, (unknown), (unknown), Kenneth Mace, Kwee Poo Yeo, (unknown), Daniel C. Howey	34
14	The future is now: Model‐based clinical trial design for Alzheimer's disease 2014 ·Clinical Pharmacology & Therapeutics ·Klaus Romero, Kaori Ito, (unknown), (unknown), Ruolun Qiu, Diane Stephenson, Richard C. Mohs, R L Lalonde, Vikram Sinha, (unknown), (unknown), Maria Isaac, Spiros Vamvakas, Robert Hemmings, Luca Pani, (unknown), Brian Corrigan, (unknown)	49
15	Predicting the Effect of Cytochrome P450 Inhibitors on Substrate Drugs: Analysis of Physiologically Based Pharmacokinetic Modeling Submissions to the US Food and Drug Administration 2014 ·Clinical Pharmacokinetics ·Christian Wagner, Yuzhuo Pan, Vicky Hsu, Joseph A. Grillo, Lei Zhang, Kellie S. Reynolds, Vikram Sinha, Ping Zhao	119
16	Assessment of glycemic response to an oral glucokinase activator in a proof of concept study: application of a semi-mechanistic, integrated glucose-insulin-glucagon model 2012 ·Journal of Pharmacokinetics and Pharmacodynamics ·Karen Schneck, (unknown), Robert J. Bauer, Mats O. Karlsson, Vikram Sinha	23
17	Dose selection using a semi-mechanistic integrated glucose-insulin-glucagon model: designing phase 2 trials for a novel oral glucokinase activator 2012 ·Journal of Pharmacokinetics and Pharmacodynamics ·(unknown), Karen Schneck, Juliana Bue‐Valleskey, Kwee Poo Yeo, Michael Heathman, Vikram Sinha	11
18	Safety, Tolerability, QTc Evaluation, and Pharmacokinetics of Single and Multiple Doses of Enzastaurin HCl (LY317615), a Protein Kinase C‐β Inhibitor, in Healthy Subjects 2007 ·The Journal of Clinical Pharmacology ·Pamela A. Welch, Vikram Sinha, Ann Cleverly, Christelle Darstein, Shawn D. Flanagan, Luna Musib	16
19	Phase I Dose Escalation and Pharmacokinetic Study of Enzastaurin, an Oral Protein Kinase C Beta Inhibitor, in Patients With Advanced Cancer 2006 ·Journal of Clinical Oncology ·Michael A. Carducci, Luna Musib, Merrill S. Kies, Роберто Пили, Mylene T. Truong, Julie R. Brahmer, Patricia E. Cole, Rana Sullivan, (unknown), (unknown), Nathan Enas, Vikram Sinha, Donald Thornton, Roy S. Herbst	150
20	Fluoxetine Pharmacokinetics in Pediatric Patients 2002 ·Journal of Clinical Psychopharmacology ·Timothy E. Wilens, Louise Glassner Cohen, Joseph Biederman, Annah N. Abrams, (unknown), (unknown), Vikram Sinha	45

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact